Risultati della ricerca - Markowitz, Martin

Resistance to Human Immunodeficiency Virus Type 1 Protease Inhibitors di Boden, Daniel, Markowitz, Martin

Testo
Testo
Testo

Rapid, Transient Changes at the env Locus of Plasma Human Immunodeficiency Virus Type 1 Populations during the Emergence of Protease Inhibitor Resistance di Delwart, Eric L., Pan, Heng, Neumann, Avidan, Markowitz, Martin

Testo
Testo
Testo

Short-Term Measures of Relative Efficacy Predict Longer-Term Reductions in Human Immunodeficiency Virus Type 1 RNA Levels following Nelfinavir Monotherapy di Mittler, John, Essunger, Paulina, Yuen, Geoffrey J., Clendeninn, Neil, Markowitz, Martin, Perelson, Alan S.

Testo
Testo
Testo

A Novel Antiviral Intervention Results in More Accurate Assessment of Human Immunodeficiency Virus Type 1 Replication Dynamics and T-Cell Decay In Vivo di Markowitz, Martin, Louie, Michael, Hurley, Arlene, Sun, Eugene, Di Mascio, Michele, Perelson, Alan S., Ho, David D.

Testo
Testo
Testo

Infectivity and Replication Capacity of Drug-Resistant Human Immunodeficiency Virus Type 1 Variants Isolated during Primary Infection di Simon, Viviana, Padte, Neal, Murray, Deya, Vanderhoeven, Jeroen, Wrin, Terri, Parkin, Neil, Di Mascio, Michele, Markowitz, Martin

Testo
Testo
Testo

Viral Blip Dynamics during Highly Active Antiretroviral Therapy di Di Mascio, Michele, Markowitz, Martin, Louie, Michael, Hogan, Christine, Hurley, Arlene, Chung, Chris, Ho, David D., Perelson, Alan S.

Testo
Testo
Testo

Dynamics of Intermittent Viremia during Highly Active Antiretroviral Therapy in Patients Who Initiate Therapy during Chronic versus Acute and Early Human Immunodeficiency Virus Typ... di Di Mascio, Michele, Markowitz, Martin, Louie, Michael, Hurley, Arlene, Hogan, Christine, Simon, Viviana, Follmann, Dean, Ho, David D., Perelson, Alan S.

Testo
Testo
Testo

Origin of Human Immunodeficiency Virus Type 1 Quasispecies Emerging after Antiretroviral Treatment Interruption in Patients with Therapeutic Failure di Kijak, Gustavo H., Simon, Viviana, Balfe, Peter, Vanderhoeven, Jeroen, Pampuro, Sandra E., Zala, Carlos, Ochoa, Claudia, Cahn, Pedro, Markowitz, Martin, Salomon, Horacio

Testo
Testo
Testo

Neutralization Profiles of Newly Transmitted Human Immunodeficiency Virus Type 1 by Monoclonal Antibodies 2G12, 2F5, and 4E10 di Mehandru, Saurabh, Wrin, Terri, Galovich, Justin, Stiegler, Gabriela, Vcelar, Brigitta, Hurley, Arlene, Hogan, Christine, Vasan, Sandhya, Katinger, Hermann, Petropoulos, Christos J., Markowitz, Martin

Testo
Testo
Testo

Genotypic Changes in Human Immunodeficiency Virus Type 1 Associated with Loss of Suppression of Plasma Viral RNA Levels in Subjects Treated with Ritonavir (Norvir) Monotherapy di Eastman, P. Scott, Mittler, John, Kelso, Reed, Gee, Chris, Boyer, Eric, Kolberg, Janice, Urdea, Mickey, Leonard, John M., Norbeck, Daniel W., Mo, Hongmei, Markowitz, Martin

Testo
Testo
Testo

Residual Viral Replication during Antiretroviral Therapy Boosts Human Immunodeficiency Virus Type 1-Specific CD8(+) T-Cell Responses in Subjects Treated Early after Infection di Ortiz, Gabriel M., Hu, Jennifer, Goldwitz, Joshua A., Chandwani, Rohit, Larsson, Marie, Bhardwaj, Nina, Bonhoeffer, Sebastian, Ramratnam, Bharat, Zhang, Linqi, Markowitz, Martin M., Nixon, Douglas F.

Testo
Testo
Testo

Human Immunodeficiency Virus Type 1 Induces Persistent Changes in Mucosal and Blood γδ T Cells despite Suppressive Therapy di Poles, Michael A., Barsoum, Shady, Yu, Wenjie, Yu, Jian, Sun, Patricia, Daly, Jeanine, He, Tian, Mehandru, Saurabh, Talal, Andrew, Markowitz, Martin, Hurley, Arlene, Ho, David, Zhang, Linqi

Testo
Testo
Testo

Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy di Zhang, Linqi, Chung, Chris, Hu, Bor-Shen, He, Tian, Guo, Yong, Kim, Alexandria J., Skulsky, Eva, Jin, Xia, Hurley, Arlene, Ramratnam, Bharat, Markowitz, Martin, Ho, David D.

Testo
Testo
Testo

Genetic Basis of Hypersusceptibility to Protease Inhibitors and Low Replicative Capacity of Human Immunodeficiency Virus Type 1 Strains in Primary Infection di Leigh Brown, Andrew J., Frost, Simon D. W., Good, Benjamin, Daar, Eric S., Simon, Viviana, Markowitz, Martin, Collier, Ann C., Connick, Elizabeth, Conway, Brian, Margolick, Joseph B., Routy, Jean-Pierre, Corbeil, Jacques, Hellmann, Nicholas S., Richman, Douglas D., Little, Susan J.

Testo
Testo
Testo

Safety and Immunogenicity of ALVAC vCP1452 and Recombinant gp160 in Newly Human Immunodeficiency Virus Type 1-Infected Patients Treated with Prolonged Highly Active Antiretroviral... di Jin, Xia, Ramanathan, Jr., Murugappan, Barsoum, Shady, Deschenes, Geoffrey R., Ba, Lei, Binley, James, Schiller, Daryl, Bauer, Daniel E., Chen, Donald C., Hurley, Arlene, Gebuhrer, Lucette, El Habib, Raphaelle, Caudrelier, Pierre, Klein, Michel, Zhang, Linqi, Ho, David D., Markowitz, Martin

Testo
Testo
Testo

HIV-1–specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy di Ortiz, Gabriel M., Nixon, Douglas F., Trkola, Alexandra, Binley, James, Jin, Xia, Bonhoeffer, Sebastian, Kuebler, Peter J., Donahoe, Sean M., Demoitie, Marie-Ange, Kakimoto, William M., Ketas, Tom, Clas, Brian, Heymann, Jonas J., Zhang, Linqi, Cao, Yunzhen, Hurley, Arlene, Moore, John P., Ho, David D., Markowitz, Martin

Testo
Testo
Testo